MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM).
Saved in:
| Title: | MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM). |
|---|---|
| Authors: | Richardson, Paul G., Perrot, Aurore, San-Miguel, Jesus, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Huang, Jeffrey Shang-Yi, Minarik, Jiri, Cavo, Michele, Prince, H Miles, Cheng Zheng, Dubin, Franck, van De Velde, Helgi, Anderson, Kenneth C. |
| Source: | Clinical lymphoma, myeloma & leukemia 2021 Supplement 1; Vol. 21. |
| Journal Info: | Publisher: Elsevier B.V. ISSN: 2152-2650 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/S2152-2650(21)01948-0 |
